A systematic literature review of methodologies used to assess medication adherence in patients with diabetes
S Clifford, M Perez-Nieves, AM Skalicky… - … medical research and …, 2014 - Taylor & Francis
Objective: Adhering to prescribed medication is often a problem for patients with diabetes
yet there is no consensus on how best to measure adherence in this patient population. This …
yet there is no consensus on how best to measure adherence in this patient population. This …
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo …
Background Improving symptoms is a primary treatment goal in patients with obstructive
hypertrophic cardiomyopathy. Currently available pharmacological options for hypertrophic …
hypertrophic cardiomyopathy. Currently available pharmacological options for hypertrophic …
Glucagon-like peptide 1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes
M Diamant, MA Nauck, R Shaginian, JK Malone… - Diabetes …, 2014 - Am Diabetes Assoc
OBJECTIVE Mealtime insulin is commonly added to manage hyperglycemia in type 2
diabetes when basal insulin is insufficient. However, this complex regimen is associated …
diabetes when basal insulin is insufficient. However, this complex regimen is associated …
[HTML][HTML] Impact of schizophrenia and schizophrenia treatment-related adverse events on quality of life: direct utility elicitation
Objective To examine the impact of schizophrenia, its treatment and treatment-related
adverse events related to antipsychotics, on quality of life from the perspective of …
adverse events related to antipsychotics, on quality of life from the perspective of …
Patient Reported Outcomes (PROs) used in recent Phase 3 trials for Type 2 Diabetes: A review of concepts assessed by these PROs and factors to consider when …
M Reaney, CA Elash, L Litcher-Kelly - Diabetes Research and Clinical …, 2016 - Elsevier
Aims Many treatment options are available for people with Type 2 Diabetes (T2D). While the
goal of treatment is to reach target HbA1c levels, the psychological experience may be more …
goal of treatment is to reach target HbA1c levels, the psychological experience may be more …
Evaluating patient-perceived control of atopic dermatitis: design, validation, and scoring of the Atopic Dermatitis Control Tool (ADCT)
DM Pariser, EL Simpson, A Gadkari… - Current Medical …, 2020 - Taylor & Francis
Abstract Objectives: The Atopic Dermatitis Control Tool (ADCT) was designed to evaluate
patient-perceived AD control and facilitate patient–physician discussion on long-term …
patient-perceived AD control and facilitate patient–physician discussion on long-term …
Development of Sinonasal Outcome Test (SNOT‐22) domains in chronic rhinosinusitis with nasal polyps
AH Khan, M Reaney, I Guillemin, L Nelson… - The …, 2022 - Wiley Online Library
Objectives/Hypothesis The 22‐item Sinonasal Outcome Test (SNOT‐22) is a validated
chronic rhinosinusitis health‐related quality‐of‐life outcome (HRQoL) measure; however …
chronic rhinosinusitis health‐related quality‐of‐life outcome (HRQoL) measure; however …
Risk of severe hypoglycemia in sulfonylurea‐treated patients from diabetes centers in Germany/Austria: How big is the problem? Which patients are at risk?
NC Schloot, A Haupt, M Schütt… - Diabetes/metabolism …, 2016 - Wiley Online Library
Background We investigated the rate of severe hypoglycemic events and confounding
factors in patients with type 2 diabetes treated with sulfonylurea at specialized diabetes …
factors in patients with type 2 diabetes treated with sulfonylurea at specialized diabetes …
The Suitability of Polycystic Ovary Syndrome‐Specific Questionnaires for Measuring the Impact of PCOS on Quality of Life in Clinical Trials
A Malik‐Aslam, MD Reaney, J Speight - Value in health, 2010 - Wiley Online Library
Objectives: Generic patient‐reported outcome (PRO) measures underestimate the impact of
polycystic ovary syndrome (PCOS) on quality of life (QoL). The aim of this review was to …
polycystic ovary syndrome (PCOS) on quality of life (QoL). The aim of this review was to …
[HTML][HTML] Patient experiences with hypertrophic cardiomyopathy: a conceptual model of symptoms and impacts on quality of life
E Zaiser, AJ Sehnert, A Duenas, S Saberi… - Journal of patient …, 2020 - Springer
Background Hypertrophic cardiomyopathy (HCM) is a primary myocardial disorder defined
by left ventricular hypertrophy that cannot be explained by another cardiac or systemic …
by left ventricular hypertrophy that cannot be explained by another cardiac or systemic …